Industry litigation – Page 18
-
Business
Halliburton settles Deepwater Horizon claims
Company will pay $1.1bn for damage to property and commercial fishing
-
Business
DuPont settles pollution charges for $1.3m
Allegations relate to eight hazardous chemical leaks in West Virginia between 2006 and 2010
-
Business
GSK’s China troubles continue
Analysts say stings will only drive corruption into less visible channels
-
Business
Tetraethyl lead bribery case ends with four executives convicted
Three jailed over corruption to prolong sales of fuel additives in Iraq and Indonesia
-
Business
Investigators find cause of West Virginia chemical spill
Holes in uninspected storage tanks led to leak that contaminated water supplies
-
Business
EMA wrangles restrain trial data progress
Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
-
Business
Inhaled insulin approved in US
European committee recommends approval for generic long-acting insulin
-
Business
Drug giants settle mismarketing lawsuits
Pfizer and GSK settle claims over promoting drugs for unapproved uses in the US
-
Business
Generics giants jostle over pain drug
Mylan and Actavis contest Teva’s generic celecoxib exclusivity
-
Business
Boehringer to settle blood thinner drug suits for $650m
Company confident in drug safety but says court cases are too risky
-
Business
Lilly protests $450m Brazilian fine
Firm says chemicals employees were allegedly exposed to were never used at site
-
Business
Chinese police hand GSK bribery case to prosecutors
Investigation alleges senior manager ordered staff to hand out bribes
-
Business
Insider trading allegations stall Sun–Ranbaxy deal
Companies deny wrongdoing in lead-up to merger announcement
-
Business
Generics triumph in anti-inflammatory patent battle
Pfizer settles deals to allow copycat celecoxib
-
Business
GSK corruption investigation widens
BBC investigation airs allegations of misconduct in Poland
-
Business
Missing safety risk emails draw $9bn Actos fine
Judge finds absence of Takeda documentation in bladder cancer case ‘disturbing’
-
Business
GSK investigates bribery claims in the Middle East
Leaked emails claim GlaxoSmithKline bribed Iraqi doctors and healthcare officials
-
Business
Anadarko agrees $5bn clean-up settlement
Record fine will address pollution at mining and manufacturing sites across the US.
-
Business
Contamination troubles strike GSK
GlaxoSmithKline is warned over contamination at an Ireland plant, and has recalled Alli from US retailers over tampering concerns.
-
Business
Lilly wins cancer drug patent dispute
Alimta patent will last until 2022 after US court rules in Lilly’s favour